Your session is about to expire
← Back to Search
Digital CBT for Anxiety in Cardiovascular Disease Patients
Study Summary
This trial will study whether digital cognitive behavioral therapy (dCBT) is an acceptable treatment for generalized anxiety disorder (GAD) in people with cardiovascular disease (CVD), and whether it is better than a waitlist control condition.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Waitlist Control
- Group 2: Digital Cognitive Behavior Therapy (dCBT) for Generalized Anxiety Disorder
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any openings for participants in this experimental trial?
"Clinicaltrials.gov affirms that recruitment for this medical trial is still underway, with the original post date being February 2nd 2022 and the last edit occurring June 1st 2022."
What is the current size of the population enrolled in this clinical research?
"Indeed, evidence hosted on clinicaltrials.gov indicates that this medical experiment is proactively recruiting patients. It was first posted on February 2nd 2022 and the most recent update occurred June 1st 2022. At present, 95 candidates need to be identified from a single test location."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger